Smith, Moore & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
+2,933
| New | +$202K | 0.02% | 494 |
|
|
2024
Q4 | – | Sell |
-2,761
| Closed | -$329K | – | 497 |
|
|
2024
Q3 | $329K | Sell |
2,761
-1,338
| -33% | -$159K | 0.03% | 345 |
|
|
2024
Q2 | $585K | Buy |
4,099
+184
| +5% | +$26.3K | 0.06% | 244 |
|
|
2024
Q1 | $503K | Buy |
3,915
+215
| +6% | +$27.6K | 0.05% | 268 |
|
|
2023
Q4 | $383K | Buy |
3,700
+700
| +23% | +$72.4K | 0.05% | 292 |
|
|
2023
Q3 | $273K | Buy |
+3,000
| New | +$273K | 0.04% | 321 |
|